31 January 2025
The Champalimaud Foundation has always been at the intersection of cutting-edge science, and exceptional care.
Specialising in cutting-edge cancer treatment, neuropsychiatry, and experimental clinical research, the Champalimaud Clinical Centre is committed to advancing personalised medicine through groundbreaking research, merging advanced technology with human-centred care.
Watch the video to see how the Champalimaud Foundation has been transforming healthcare and improving lives for the past 20 years—and how we’ll continue to do so in the future.
23 January 2025
London taxi drivers have specialised human mental strategies for expertly navigating their city’s streets, scientists find
An international team of scientists, including a principal investigator in neuroscience from the Champalimaud Foundation, in Lisbon, has analysed the way expert London taxi drivers plan their route in advance every time they pick up passengers. It is the first time a study about human planning has been performed in a real-world, large-scale environment. Their results are published today (23rd of January) in the Proceedings of the National Academy of Sciences.
21 January 2025
The Potential—and Pitfalls—of Psychedelic Therapies for Psychiatric Disorders
Over the past decade, interest in psychedelics—including psilocybin, LSD, and MDMA—as treatments for psychiatric disorders has grown exponentially among scientists, mental health professionals, the media, and the public.
17 January 2025
Champalimaud Foundation: 20 years at the service of humanity
From groundbreaking scientific research to compassionate, patient-centered clinical care, the Foundation is committed to developing innovative solutions for complex challenges, all with the goal of improving lives and inspiring hope.
Founded in the beginning of the 21st century, it carries forward the visionary legacy of António Champalimaud, advancing science and healthcare for the greater good of humanity.
Join us in discovering how, together, we are shaping a brighter future.
16 January 2025
Eavesdropping on organs: immune system controls blood sugar levels
During periods of low energy—such as intermittent fasting or exercise—immune cells step in to regulate blood sugar levels, acting as the “postman” in a previously unknown three-way conversation between the nervous, immune and hormonal systems. These findings open up new approaches for managing conditions like diabetes, obesity, and cancer.
Champalimaud Open Seminars: Carlos Minutti
Date and time:
20 January 2025 – 12:00
Location:
Champalimaud Foundation Auditorium
Description:
Conventional Dendritic Cells – Ecology, Diversity, and Functio
Carlos Minutti (Immunoregulation Lab)
Moderator: Cristina João (Myeloma Lymphoma Research Group)
Alternative Mathematical Approaches in AI (ALTAI2025)
The aim of this 2-days meeting, is to bring together experts working on innovative AI methodologies, for example: Physics-Inspired Machine Learning, New Statistical Approaches, Quantum Machine Learning, Bayesian Methods, Neurosymbolic Methods, Symbolic AI, Automated Theorem Proving, Probabilistic Programming Languages, Algebraic Machine Learning, Category Theory applied to AI.
Date: 3-4 February, 2025
Further information on the official website.
17 December 2024
More calories – more consumption
Higher calorie foods were preferred among individuals with and without obesity despite similar taste and texture, according to a study published December 17th in the open-access journal PLOS Biology by Albino Oliveira-Maia from the Champalimaud Foundation, Portugal, and colleagues.
